(3R)-3-(Difluoromethoxy)piperidine hydrochloride, 98%, 100mg

5-Hydroxymethylfurfural, min. 97%, for synthesis, 250 mg, glass packaging

Potassium trifluoro(4-trifluoromethylphenyl)borate, 97.0%, 5g

Pomalidomide-PEG1-azide, 95%, 25mg

1-(2,2-Diethoxyethyl)pyrrolidine, 95+%, 1g

sodium 2-(1,3-benzothiazol-2-yl)acetate, 1g

1-(2,4-Difluorophenyl)-3-(p-tolylthio)pyrrolidine-2,5-dione, 95.0%, 1g

GC capillary column ROTI®Cap-1701, 15 m, 0.32 mm, 0.25 µm, 1 Piece(s)

6-iodo-2-methoxypyridin-3-ol, 95.0%, 500mg

Methyl 2-methoxy-4-methyl-5-nitrobenzoate, 96%, 1g

1-[1-(2-methoxyethyl)piperidin-4-yl]-N-methylmethanamine, 95.0%, 1g

2,2-Dioxo-1-methyl-2,1-benzothiazin-4(3H)-one, 1g

2-Bromothiazole-4-carboxamide, 95.0%, 5g